Waters Corporation (NYSE:WAT) Director Thomas P. Salice sold 3,500 shares of the company’s stock in a transaction on Monday, November 20th. The shares were sold at an average price of $200.03, for a total value of $700,105.00. Following the completion of the transaction, the director now directly owns 20,349 shares in the company, valued at approximately $4,070,410.47. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Waters Corporation (NYSE:WAT) traded down $2.21 during trading on Wednesday, hitting $198.06. 615,900 shares of the stock traded hands, compared to its average volume of 518,500. The company has a debt-to-equity ratio of 0.66, a quick ratio of 5.71 and a current ratio of 6.16. Waters Corporation has a fifty-two week low of $133.35 and a fifty-two week high of $200.71. The stock has a market cap of $15,650.00, a PE ratio of 27.82, a P/E/G ratio of 2.91 and a beta of 0.82.
Waters Corporation (NYSE:WAT) last posted its quarterly earnings results on Tuesday, October 24th. The medical instruments supplier reported $1.77 EPS for the quarter, beating the consensus estimate of $1.74 by $0.03. Waters Corporation had a net margin of 24.34% and a return on equity of 23.61%. The business had revenue of $565.58 million for the quarter, compared to analysts’ expectations of $555.25 million. During the same period in the previous year, the company posted $1.57 EPS. Waters Corporation’s revenue was up 7.4% on a year-over-year basis. research analysts anticipate that Waters Corporation will post 7.42 earnings per share for the current year.
ILLEGAL ACTIVITY WARNING: “Waters Corporation (WAT) Director Thomas P. Salice Sells 3,500 Shares” was originally published by TrueBlueTribune and is owned by of TrueBlueTribune. If you are viewing this story on another domain, it was stolen and reposted in violation of US & international copyright and trademark law. The legal version of this story can be read at https://www.truebluetribune.com/2017/11/22/waters-corporation-wat-director-thomas-p-salice-sells-3500-shares.html.
Several institutional investors have recently bought and sold shares of WAT. Oppenheimer Asset Management Inc. grew its holdings in shares of Waters Corporation by 0.4% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 573 shares of the medical instruments supplier’s stock valued at $105,000 after acquiring an additional 2 shares in the last quarter. ETF Managers Group LLC purchased a new position in shares of Waters Corporation during the 2nd quarter valued at $106,000. Intellectus Partners LLC grew its holdings in shares of Waters Corporation by 4.9% during the 2nd quarter. Intellectus Partners LLC now owns 667 shares of the medical instruments supplier’s stock valued at $123,000 after acquiring an additional 31 shares in the last quarter. First Manhattan Co. purchased a new position in shares of Waters Corporation during the 2nd quarter valued at $130,000. Finally, Edmond DE Rothschild Holding S.A. purchased a new position in shares of Waters Corporation during the 2nd quarter valued at $160,000. Institutional investors and hedge funds own 92.04% of the company’s stock.
Several research analysts have issued reports on the company. Bank of America Corporation upped their price target on Waters Corporation from $192.00 to $202.00 and gave the company a “neutral” rating in a report on Friday, November 10th. Cowen and Company reaffirmed a “hold” rating and issued a $190.00 price target on shares of Waters Corporation in a report on Friday, November 3rd. Zacks Investment Research cut Waters Corporation from a “buy” rating to a “hold” rating in a report on Thursday, October 26th. Citigroup Inc. reaffirmed a “neutral” rating and issued a $180.00 price target on shares of Waters Corporation in a report on Wednesday, October 25th. Finally, Barclays PLC upped their price target on Waters Corporation from $188.00 to $193.00 and gave the company an “equal weight” rating in a report on Wednesday, October 25th. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $193.62.
Waters Corporation Company Profile
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Receive News & Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related companies with MarketBeat.com's FREE daily email newsletter.